rs1057521721
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000828.5(GRIA3):c.1957G>A(p.Ala653Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A653S) has been classified as Pathogenic.
Frequency
Consequence
NM_000828.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRIA3 | NM_000828.5 | c.1957G>A | p.Ala653Thr | missense_variant | 12/16 | ENST00000622768.5 | |
GRIA3 | NM_007325.5 | c.1957G>A | p.Ala653Thr | missense_variant | 12/16 | ENST00000620443.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRIA3 | ENST00000620443.2 | c.1957G>A | p.Ala653Thr | missense_variant | 12/16 | 1 | NM_007325.5 | P4 | |
GRIA3 | ENST00000622768.5 | c.1957G>A | p.Ala653Thr | missense_variant | 12/16 | 5 | NM_000828.5 | A1 | |
GRIA3 | ENST00000620581.4 | c.1957G>A | p.Ala653Thr | missense_variant, NMD_transcript_variant | 12/17 | 1 |
Frequencies
GnomAD3 genomes ? Cov.: 22
GnomAD4 exome Cov.: 28
GnomAD4 genome ? Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 05, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 653 of the GRIA3 protein (p.Ala653Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of GRIA3-related conditions (PMID: 29016847; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 383739). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GRIA3 protein function. Experimental studies have shown that this missense change affects GRIA3 function (PMID: 29016847). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2022 | Published functional studies demonstrate a damaging effect on channel function (Davies et al., 2017); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29016847, 32977175) - |
Syndromic X-linked intellectual disability 94 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Disrupted sleep-wake cycle with developmental delay and learning difficulty Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing;in vitro;in vivo | Barrett Group, Wellcome Trust Sanger Institute | May 25, 2017 | This was the most likely causal variant identified in this family quartet. GRIA3 encodes GluA3, a subunit of AMPA-type ionotropic glutamate receptors, and has been previously implicated in intellectual disability. The mutation (Ala653Thr) falls within the highly conserved transmembrane domain of the ion channel gate. In vitro, the GRIA3(A653T) mutation stabilizes the channel in the closed conformation. We introduced the orthologous mutation into a mouse strain with CRISPR and found that hemizygous mutants displayed significant differences in the structure of their activity and sleep compared to wild-type littermates. These mutant mice showed significantly fewer brief bouts of activity and sleep than the wild-types. Furthermore, they showed enhanced period lengthening under constant light compared to wild-type mice, suggesting an increased sensitivity to light. Our results suggest a role for GluA3 channel activity in regulation of sleep behavior in both mice and humans. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2016 | The p.A653T variant (also known as c.1957G>A), located in coding exon 12 of the GRIA3 gene, results from a G to A substitution at nucleotide position 1957. The alanine at codon 653 is replaced by threonine, an amino acid with similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at